» Articles » PMID: 34640423

From Basic Mechanisms to Clinical Research: Photodynamic Therapy Applications in Head and Neck Malignancies and Vascular Anomalies

Overview
Journal J Clin Med
Specialty General Medicine
Date 2021 Oct 13
PMID 34640423
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Head and neck cancers are largely squamous cell carcinomas derived from the epithelial lining of the structures in the region, and are often classified anatomically into oral, oropharyngeal, nasopharyngeal and laryngeal carcinomas. The region's component structures serve complex and intricate functions, such as speaking, swallowing and breathing, which are often compromised by these neoplasms. Such lesions may also cause disfigurement, leading to distressing social and psychological issues. Conventional treatments of these neoplasms usually involve surgical intervention with or without chemoradiotherapy. These have shown to be efficacious; however, they can also cause damage to healthy as well as diseased tissue, exacerbating the aforementioned problems. Access to a given region to deliver the treatments is also often a problem, due to the complex anatomical structures involved. The use of photodynamic therapy in the head and neck region has been established for about two decades. In this review, we looked at the basic mechanisms of this intervention, examined its use in common head and neck malignancies and vascular anomalies, and reported on the most recent clinical studies. We further included a clinical guide which can help replicate the use of this technology by any unit. Based on this review, photodynamic therapy has been shown to be efficacious in the treatment of head and neck malignancies and vascular tumours. This therapy can be targeted to the diseased tissue and causes no damage to underlying structures. Recent studies have shown this therapy to be as effective as conventional therapies, without causing major adverse effects.

Citing Articles

In vivo, online label-free monitoring of heterogenous oxygen utilization during phototherapy with real-time ultrasound-guided photoacoustic imaging.

Langley A, Sweeney A, Shethia R, Bednarke B, Wulandana F, Xavierselvan M bioRxiv. 2024; .

PMID: 39677615 PMC: 11642742. DOI: 10.1101/2024.11.27.625759.


Photodynamic Therapy: Past, Current, and Future.

Aebisher D, Czech S, Dynarowicz K, Misiolek M, Komosinska-Vassev K, Kawczyk-Krupka A Int J Mol Sci. 2024; 25(20).

PMID: 39457108 PMC: 11508366. DOI: 10.3390/ijms252011325.


Nanoencapsulation of a Far-Red Absorbing Phthalocyanine into Poly(benzylmalate) Biopolymers and Modulation of Their Photodynamic Efficiency.

Sahin Z, Onal E, Ali L, Durand D, Emami A, Toure M Biomacromolecules. 2024; 25(6):3261-3270.

PMID: 38752976 PMC: 11170942. DOI: 10.1021/acs.biomac.3c01382.


Photodynamic Therapy for Eye, Ear, Laryngeal Area, and Nasal and Oral Cavity Diseases: A Review.

Domka W, Bartusik-Aebisher D, Mytych W, Mysliwiec A, Dynarowicz K, Cieslar G Cancers (Basel). 2024; 16(3).

PMID: 38339396 PMC: 10854993. DOI: 10.3390/cancers16030645.


Effects of Kojic Acid-mediated Sonodynamic Therapy as a Matrix Metalloprotease-9 Inhibitor against Oral Squamous Cell Carcinoma: A Bioinformatics Screening and Analysis.

Pourhajibagher M, Alaeddini M, Etemad-Moghadam S, Parker S, Bahador A Curr Drug Discov Technol. 2023; 21(4):e011223224137.

PMID: 38073102 DOI: 10.2174/0115701638266082231124055825.


References
1.
Shafirstein G, Rigual N, Arshad H, Cooper M, Bellnier D, Wilding G . Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide-a for early-stage cancer of the larynx: Phase Ib study. Head Neck. 2015; 38 Suppl 1:E377-83. PMC: 4499022. DOI: 10.1002/hed.24003. View

2.
Warnakulasuriya S . Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2008; 45(4-5):309-16. DOI: 10.1016/j.oraloncology.2008.06.002. View

3.
von Beckerath M, Reizenstein J, Berner A, Nordqvist K, Landstrom F, Lofgren A . Outcome of primary treatment of early laryngeal malignancies using photodynamic therapy. Acta Otolaryngol. 2014; 134(8):852-8. DOI: 10.3109/00016489.2014.906748. View

4.
Castano A, Mroz P, Hamblin M . Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer. 2006; 6(7):535-45. PMC: 2933780. DOI: 10.1038/nrc1894. View

5.
Hosokawa S, Takebayashi S, Takahashi G, Okamura J, Mineta H . Photodynamic therapy in patients with head and neck squamous cell carcinoma. Lasers Surg Med. 2018; 50(5):420-426. DOI: 10.1002/lsm.22802. View